Six AI Stocks Rise 13%–66%, Generic-Drug Maker Leads Gains

Published on 10/28/2026 · Source: investing.com

AI Summary

Summarized by AI from the source below

Six stocks selected for their artificial intelligence (AI) potential have increased in value between 13% and 66% since their initial recommendation. The highest performer among these is a generic-drug maker, which leads the group in gains.

This performance highlights varying returns across AI-related investments, with significant growth seen in this specific healthcare sector player. The article does not provide individual stock names or exact entry dates but specifies the range of percentage gains.

For investors, these gains suggest selective opportunities within AI stocks, particularly in sectors like healthcare where AI technologies may intersect with drug manufacturing. The percentage increases offer concrete figures to assess AI investment returns over the given period.

Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.

Our take

Opinion from the Newsstocks AI desk, not investment advice

The article presents factual data on varied gains among AI-focused stocks without naming specific companies or dates. In our view, these percentage returns indicate selective success within the AI investment space, especially for healthcare-linked firms. More detailed data would help assess sustainability and broader trends.

Key numbers

Minimum gain: 13%
Maximum gain: 66%

What could help

Strong performance by a generic-drug maker shows AI may boost healthcare industry stocks.

The background

Stock gains refer to the increase in price from the time of purchase to current value. AI picks are stocks chosen for their potential to benefit from artificial intelligence technology.